FEATURED

Older Patients Not Averse to Treatment

Some say older patients are not being offered the same access to cancer care as younger patients.

We Can Treat Lymphoma Like Melanoma?

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Study: mRCC Patient Survival Improving

A population-based study found survival benefit for metastatic renal cell carcinoma correlated with shift from cytokines to targeted therapies.

Drug Showcase: ODOMZO (sonidegib)

For locally advanced basal cell carcinoma.

ASCO Updates Lung Cancer Therapy Guideline

ASCO updates the metastatic lung cancer guideline to include the early integration of palliative care for patients with stage 4 non-small cell lung cancer.

Immunotherapy Combinations Show Promise

Pivotal phase 3 trials show promising top-line findings for patients with metastatic renal cell carcinoma.

Obesity and Gastrointestinal Cancer

Obesity is now recognized as one of the foremost modifiable cancer risk factors.

Oxaliplatin-induced Neuropathy in Cycle One

Acute peripheral neuropathy often does not resolve between cycles of treatment and severity often increases between cycles.

Dasatinib-induced PAH in Patients With Leukemia

Ultimately, pulmonary arterial hypertension may occur in as many as 5% of patients with leukemia being treated with dasatinib.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

New Study Suggests Older Adults Not More Likely to Refuse Cancer Treatment

New Study Suggests Older Adults Not More Likely to Refuse Cancer Treatment

Some say older patients are not being offered the same access to cancer care as younger patients.

"Real-World" Survival for Renal Cell Carcinoma Patients Improving

"Real-World" Survival for Renal Cell Carcinoma Patients Improving

A population-based study found survival benefit for metastatic renal cell carcinoma correlated with shift from cytokines to targeted therapies.

Feature Articles

We Can Treat Hodgkin's Lymphoma Like Melanoma?

We Can Treat Hodgkin's Lymphoma Like Melanoma?

Isabel Cunningham, MD, Cancer Therapy Advisor Advisory Board member, weighs in on recent discoveries in the treatment of hematologic cancers.

Immunotherapy Combinations for Renal Cell Carcinoma Offer Promise, Challenges

Immunotherapy Combinations for Renal Cell Carcinoma Offer Promise, Challenges

Pivotal phase 3 trials show promising top-line findings for patients with metastatic renal cell carcinoma.

Featured Videos

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs